FDA clears Omnipod DASH
By HME News Staff
Updated Wed June 6, 2018
BILLERICA, Mass. - Insulet Corp. has received clearance from the U.S. Food and Drug Administration for its Omnipod DASH Insulin Management System. The Omnipod DASH features an easy-to-read, touch-screen PDM; user-friendly steps to manage basal rates; and a food library. Bluetooth technology allows for connectivity between the device and the Pod, as well as the Omnipod Display and View apps. It also allows users to monitor their data on their smart phones. “Omnipod DASH was inspired by Podders and embodies what users on multiple daily injections have been asking for in a diabetes management system,” said Patrick Sullivan, chairman and CEO. “Our No. 1 priority is to continue to minimize the daily strain on those impacted by diabetes and we are confident this system, and eliminating the system's upfront cost, do just that.” The DASH is free with the purchase of Pods.
Comments